- Home
- EVH vs AUPH Comparison
EVH vs AUPH Comparison
Compare EVH & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVH
- AUPH
- Stock Information
- Founded
- EVH 2011
- AUPH 1993
- Country
- EVH United States
- AUPH Canada
- Employees
- EVH N/A
- AUPH N/A
- Industry
- EVH Other Consumer Services
- AUPH Biotechnology: Pharmaceutical Preparations
- Sector
- EVH Consumer Discretionary
- AUPH Health Care
- Exchange
- EVH Nasdaq
- AUPH Nasdaq
- Market Cap
- EVH 1.1B
- AUPH 1.1B
- IPO Year
- EVH 2015
- AUPH 1999
- Fundamental
- Price
- EVH $10.07
- AUPH $8.19
- Analyst Decision
- EVH Strong Buy
- AUPH Strong Buy
- Analyst Count
- EVH 14
- AUPH 2
- Target Price
- EVH $16.71
- AUPH $11.50
- AVG Volume (30 Days)
- EVH 2.3M
- AUPH 1.3M
- Earning Date
- EVH 05-08-2025
- AUPH 05-01-2025
- Dividend Yield
- EVH N/A
- AUPH N/A
- EPS Growth
- EVH N/A
- AUPH N/A
- EPS
- EVH N/A
- AUPH 0.04
- Revenue
- EVH $2,554,741,000.00
- AUPH $235,133,000.00
- Revenue This Year
- EVH N/A
- AUPH $11.86
- Revenue Next Year
- EVH $16.02
- AUPH $24.96
- P/E Ratio
- EVH N/A
- AUPH $204.13
- Revenue Growth
- EVH 30.09
- AUPH 33.97
- 52 Week Low
- EVH $8.35
- AUPH $4.71
- 52 Week High
- EVH $33.63
- AUPH $10.67
- Technical
- Relative Strength Index (RSI)
- EVH 56.23
- AUPH 48.74
- Support Level
- EVH $9.29
- AUPH $7.93
- Resistance Level
- EVH $9.70
- AUPH $8.73
- Average True Range (ATR)
- EVH 0.41
- AUPH 0.23
- MACD
- EVH 0.06
- AUPH -0.04
- Stochastic Oscillator
- EVH 84.21
- AUPH 32.50
About EVH Evolent Health Inc
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.